iconEarnings Announcement Before Market Open

Precision BioSciences Inc DTIL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
10.57quote price arrow down-0.09 (-0.84%)
Volume
31,132
52 week range
8.25 - 27.02
Loading...
  • Open10.75
  • Day High10.75
  • Day Low10.12
  • Prev Close10.66
  • 52 Week High27.02
  • 52 Week High Date05/24/23
  • 52 Week Low8.25
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap73.105M
  • Shares Out6.92M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-3.47

KEY STATS

  • Open10.75
  • Day High10.75
  • Day Low10.12
  • Prev Close10.66
  • 52 Week High27.02
  • 52 Week High Date05/24/23
  • 52 Week Low8.25
  • 52 Week Low Date10/27/23
  • Market Cap73.105M
  • Shares Out6.92M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-3.47

RATIOS/PROFITABILITY

  • EPS (TTM)-16.38
  • P/E (TTM)-0.65
  • Fwd P/E (NTM)-1.44
  • EBITDA (TTM)-36.919M
  • ROE (TTM)-107.26%
  • Revenue (TTM)48.727M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-87.28%
  • Debt To Equity (MRQ)118.83%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Precision BioSciences Inc

 

Profile

MORE
Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using ARCUS, the Company's pipeline consists of in vivo gene editing candidates designed to deliver cures for a range of genetic and infectious diseases. The ARCUS platform develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision. ARCUS particularly generates defined outcomes...
Kevin Buehler
Independent Chairman of the Board
Michael Amoroso
President, Chief Executive Officer, Director
Alex Kelly
Chief Financial Officer
Dario Scimeca
General Counsel, Secretary
Address
302 E Pettigrew St Ste A100
Durham, NC
27701-2393
United States

Top Peers

SYMBOLLASTCHG%CHG
PLX
Protalix Biotherapeutics Inc
1.14+0.03+2.70%
PIRS
Pieris Pharmaceuticals Inc
11.04-0.02-0.18%
EQ
Equillium Inc
1.78+0.06+3.49%
MTEM
Molecular Templates Inc
1.61-0.03-1.83%
PRE
Prenetics Global Ltd
5.70-0.08-1.38%